Decreased brain creatine levels in elderly apolipoprotein E ε4 carriers

Journal of Neural Transmission

Volumn 110, Issue 3, 2003, Pages 267-275

  Laakso, M P ^a,b   Hiltunen, Y ^a   Kononen M ^a,b   Kivipelto, M ^a   Koivisto, A ^a   Hallikainen, M ^a   Soininen, H ^a  

^a Raahe Inst of Computer Engineering   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aging; Apolipoprotein; Brain; Creatine; Genetics; Imaging; Magnetic resonance; Metabolism; Spectroscopy

Indexed keywords

ACYLTRANSFERASE; APOLIPOPROTEIN E4; CHOLINE; CREATINE; GENE PRODUCT; INOSITOL;

AGED; AGING; ALLELISM; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HUMAN; MALE; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PRIORITY JOURNAL; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; CHI-SQUARE DISTRIBUTION; CREATINE; FEMALE; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTAL STATUS SCHEDULE;

EID: 0037348216     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0783-7     Document Type: Article

References (31)

1. Andreassen OA, Jenkins BG, Dedeoglu A, Ferrante KL, Bogdanov MB, Kaddurah-Daouk R, Beal MF (2001) Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. J Neurochem 77: 383-390
2. Becker JT, Mintun MA, Aleva K, Wiseman MB, Nichols T, DeKosky ST (1996) Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology 46: 692-700
3. Brewer GJ, Wallimann TW (2000) Protective effect of the energy precursor creatine against toxicity of glutamate and β-amyloid in rat hippocampal neurons. J Neurochem 74: 1968-1978
4. Bäckman L, Andersson JLR, Nyberg L, Winblad B, Nordberg A, Almkvist O (1999) Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 52: 1861-1870
5. Castillo M, Kwock L, Mukherji SK (1996) Clinical applications of proton MR spectroscopy. Am J Neuroradiol 17: 1-15
6. Dechent P, Pouwels PJW, Wilken B, Hanefeld F, Frahm J (1999) Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Physiol 277: R698-R704
7. Ernst T, Chang L, Melchor R, Mehringer CM (1997) Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203: 829-836
8. Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 20: 4389-4397
9. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198
10. Grady CL, Haxby JV, Horwitz B, Gillette J, Salerno JA, Gonzalez-Aviles A, Carson RE, Herscovitch P, Schapiro MB, Rapoport SI (1993) Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol Aging 14: 35-44
11. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548
12. 1H MRS study. Am J Psychiatry 156: 1879-1886
13. 1H MRS study. Neurology 57: 626-632
14. Jackson EF, Meyers CA (1997) Introduction to hippocampal spectroscopy. Neuroimag Clin North Am 7: 143-154
15. 1H NMR spectra. J Magn Reson 134: 176-179
16. Klunk WE, Panchalingam K, McClure RJ, Stanley JA, Pettegrew JW (1998) Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4. Neurobiol Aging 19: 511-515
17. Lehtovirta M, Laakso MP, Frisoni GB, Soininen H (2000) How does the apolipoprotein E genotype modulate the brain in aging and Alzheimer's disease? A review of neuroimaging studies. Neurobiol Aging 21: 293-300
18. Middelkoop HAM, van der Flier WM, Burton EJ, Lloyd AJ, Paling S, Barber R, Ballard C, McKeith IG, O'Brien JT (2001) Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology 57: 2117-2120
19. Pettegrew JW, Klunk WE, Kanal E, Panchalingam K, McClure RJ (1995). Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia. Neurobiol Aging 16: 973-975
20. Rai GS, McConnell JR, Waldman A, Grant D, Chaudry M (1999) Brain proton spectroscopy in dementia: an aid to clinical diagnosis. Lancet 353: 1063-1064
21. Rosen WG, Terry RD, Fuld PA, Katzman R, Beck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 17: 486-488
22. Rudkin TM, Arnold DL (1999) Proton magnetic resonance spectropscopy for the diagnosis and management of cerebral disorders. Arch Neurol 56: 919-926
23. Schuff N, Amend D, Ezekiel F, Steinamn SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW (1997) Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. Neurology 49: 1513-1521
24. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346: 476-483
25. Shonk T, Ross BD (1995) Role of increased myo-inositol in the dementia of Down syndrome. Magn Reson Med 33: 858-861
26. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD (1995) Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 195: 65-72
27. Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Moussai J, Holmes CJ, Cummings JL, Toga AW (2001) Cortical change in Alzheimer's disease detected with a disease-specific population-based atlas. Cereb Cortex 11: 1-16
28. 1H magnetic resonance spectra. In: McWhirter JG (ed) Mathematics in signal processing III. Clarendon Press, Oxford, pp 175-195
29. Watanabe A, Kato N, Kato T (2002) Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 42: 279-285
30. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80: 1107-1213
31. Wyss M, Schulze A (2002) Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112: 243-260